Drug recall · April 8, 2026
traMADol Hydrochloride Tablets recall
Why: Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, India, Distributed by: Amneal Pharmaceuticals LLC, Glasgow, KY 42141, NDC 60219-2348-5.
- Lots / codes
Lot #: AM230987, Exp. Date 05/2026; AR232387, Exp. Date 12/2026.
- Quantity
- 29,542 bottles
- Company
- Amneal Pharmaceuticals, LLC, Bridgewater, NJ
- Distribution
- Nationwide within the USA
- Initiated
- March 19, 2026 · Voluntary: Firm initiated
- Classified
- March 30, 2026
- Reported
- April 8, 2026
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tramadol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.